Digest Network Come funziona
Network
/
Società
Pf
Non verificato

Pfizer Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

95 comunicati stampa

Guarda tutti i comunicati
05/01/2026
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
18/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
16/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Biotecnologia
Farmaceutica
Salute
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
12/12/2025
Titoli e azioni
Biotecnologia
Salute
Scienza
Farmaceutica
Pfizer Declares First-Quarter 2026 Dividend
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
10/12/2025
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
09/12/2025
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
06/12/2025
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Eventi
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
01/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Biotecnologia
Farmaceutica
Salute
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
21/11/2025
Multimedialità
Mercato del lavoro
Eventi
Industria
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
13/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato azionario
Pfizer Completes Acquisition of Metsera
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0